Supernus Pharmaceuticals, Inc. (SUPN)

Market price: $40.96

3 valuation methods

• EV / Revenue: $32.00 to $105.46 (midpoint $41.93)
• DCF (FCFF): $40.79 to $54.12 (midpoint $46.48)
• P / B: $48.67 to $126.15 (midpoint $72.03)

Pre-profit company — earnings-based methods not meaningful.